INTRODUCTION
============

Stroke is one of the major causes of dysfunction and death worldwide ([@b2-jer-14-2-267]), due to acute cerebrovascular disease that causes paralysis on one side of the body, accompanied by a sudden onset of consciousness due to cerebrovascular bleeding and infarction ([@b39-jer-14-2-267]). Factors such as race, age, sex, hypertension, smoking, diabetes, hyperlipidemia, obesity, and physical inactivity have traditionally been reported as risk factors for stroke and recent studies have shown that elevated levels of homocysteine (Hcy) in the blood are associated with the incidence of stroke ([@b36-jer-14-2-267]).

It is also reported that cognitive impairment, which increases with age, is caused by stroke. Epidemiological studies have shown that patients with stroke have a higher risk of developing dementia than the normal population ([@b28-jer-14-2-267]; [@b40-jer-14-2-267]). Within 3 months after stroke, the cognitive function reduces by 23% to 55%, and it reduces by 11% to 31% within 1 year ([@b46-jer-14-2-267]). Moreover, stroke increases the prevalence of dementia by 4 to 12 times ([@b28-jer-14-2-267]). The mechanism behind development of dementia after the onset of stroke has not been clarified yet, but it is suggested that the level of Hcy in blood is related to the risk of stroke ([@b17-jer-14-2-267]).

Elevated serum Hcy levels induce inflammatory responses, affect the inflammatory function of endothelial cells at the gene expression stage ([@b38-jer-14-2-267]), and increase oxidative stress ([@b21-jer-14-2-267]). The highly reactive thiol group of Hcy is readily oxidized to the active form ([@b29-jer-14-2-267]), resulting in auto-oxidation and oxidative damage of Hcy, which has been reported to cause cognitive impairment, neurotoxicity ([@b35-jer-14-2-267]), and brain damage ([@b41-jer-14-2-267]).

Physical inactivity and low cardiorespiratory fitness are major risk factors for cardiovascular disease and indicate the prevalence of and mortality from all diseases ([@b25-jer-14-2-267]). Regular exercise increases cardiorespiratory fitness, and decreases cardiovascular disease and cognitive function in elderly individuals ([@b19-jer-14-2-267]). It has been suggested that the risk of recurrent stroke and prevalence of dementia may be lowered by exercise ([@b22-jer-14-2-267]).

However, exercise training was reported to decrease or maintain Hcy concentrations ([@b12-jer-14-2-267]; [@b37-jer-14-2-267]) or even increase them after endurance training ([@b16-jer-14-2-267]). Therefore, the effect of physical activity on Hcy concentration is still unclear.

These results can be explained by the effect of genetic factors and dietary intake on Hcy levels. The lack of coenzyme required for the metabolism of Hcy affects its elevation in the blood. If nutrient intake required for the metabolism of remethylated methionine is insufficient, i.e., in the presence of reduced levels of vitamin B~6~, vitamin B~9~ (folic acid), and vitamin B~12~ or when there is a lack of enzymatic activity required for Hcy metabolism, conversion to cysteine is not achieved, which induces an elevation in the concentration of Hcy in the blood ([@b5-jer-14-2-267]).

In addition, the apolipoprotein E (*APOE*) gene has also been suggested to associate with stroke and dementia. APOE plays an important role in metabolism and cholesterol transport ([@b24-jer-14-2-267]). The APOE E4 allele binds to low-density lipoprotein (LDL) receptors but is related to elevations in cholesterol ([@b31-jer-14-2-267]), which increases the risk of cardiovascular disease, stroke, and dementia ([@b15-jer-14-2-267]). However, the effects of exercise training on dementia according to the APOE genotype are not consistent as reported in the literature. [@b1-jer-14-2-267] reported that individuals who lack the APOE E4 allele showed a significant increase in the related brain factors after 6 months of exercise training while individuals with APOE E4 did not. Another study reported that the risk of developing dementia was not significantly different between nonexercisers and exercisers after a 5-year follow-up in individuals with the APOE E4 allele while, the risk was higher in nonexercisers than exercisers among individuals who lack the APOE E4 allele.

Therefore, this study aimed to investigate the effects of combined aerobic and resistance exercise on the risk for stroke, including blood pressure, lipid profiles, Hcy concentrations, and cognitive function, according to the *APOE* genotype along with dietary intervention.

METERIALS AND METHODS
=====================

Subjects
--------

The study participants were 68 ischemic stroke patients. Informed consent was obtained from all subjects before their participation. A questionnaire assessed the medical history of study subjects. Subjects were excluded based on the following criteria: (1) intake of drugs (folate, vitamin B~6~, and B~12~ antagonists, etc.) that change plasma Hcy concentration, (2) excess of coffee (\>4 cups) and alcohol (\>2 cups) consumption, (3) comorbid diseases like coronary artery disease, (4) cigarette smoking, and (5) female sex, because plasma Hcy concentrations are affected by gender.

After explaining the purpose and procedure of the study to the participants, we collected blood samples, which were subjected to APOE genotype analysis. Of the 68 subjects, we identified 0 (0%) stroke patients with the ɛ2 genotype, 31 (45.58%) with the ɛ3 genotype (ɛ2/ɛ3 and ɛ3/ɛ3), and 37 (54.42%) with the ɛ4 genotype (ɛ3/ɛ4 and ɛ4/ɛ4) in this study. Results of this screening were used to classify subjects into the ɛ3 (n=13) or ɛ4 (n=15) genotype groups ([Table 1](#t1-jer-14-2-267){ref-type="table"}).

Anthropometry measurements
--------------------------

Before and after the exercise training, anthropometric measurements were obtained for all subjects. Height and body weight were also recorded (Tanita, Seoul, Korea) and body mass index (BMI) was calculated from the ratio of weight (kg)/height (m^2^).

Cognition measurements
----------------------

To examine the cognitive function in participants, the Mini-Mental State Examination (MMSE) developed by [@b9-jer-14-2-267] was used. To examine the cognition function of Korean elderly people, we used the simplified Korean version of MMSE (MMSE-K). MMSE-K is the most commonly used test method for cognitive function. It has 5 points of commands and orientation, 3 points of recall, 5 points of attention and calculation, 3 points of memory, 7 points of language, and 2 points of judgment and understanding. A higher score implies a higher cognitive function. A score below 20 implies cognitive impairment, from 21 to 23 implies cognitive impairment, and 24 or more implies normal status.

Ascertainment of diet intake
----------------------------

Diet intake was ascertained by interviewer-mediated 24-hr recall. Three-day diets were completed during the exercise training period, including 2 days on weekdays and 1 day on weekends. Food composition values for folate, vitamin B~6~ and other macro-nutrients were obtained using Can pro professional 3.0 (The Korean Nutrition Society, Seoul, Korea) based on the Korean nutrient data base. Unfortunately, we could not examine vitamin B12intake, owing to limited data in Can pro professional 3.0. During the exercise-training period, nutrition education was provided to the stroke patients. However, nutritional intervention was not provided in order to verify the effect of exercise training.

Blood collection and assessment of biomarkers
---------------------------------------------

Serum aliquots were stored at −80ºC until assayed. Total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were measured using an enzymatic colorimetric method and analyzed by the COBAS integra 800 (Roche Korea, Seoul, Korea). Plasma glucose levels were measured using a commercially available kit. Hcy was determined by FPLC, using a radiometric tyrosine assay.

Genotyping
----------

Total blood DNA was extracted and purified from 200 μL of whole blood in anticoagulant tubes with ethylenediaminetetraacetic acid, using the Axygen DNA Blood Mini Kit according to manufacturer's instructions (Axygen Biosciences, Seoul, Korea). Genotyping of the APOE status was performed using the method described by [@b13-jer-14-2-267]. APOE polymorphism was tested using the polymerase chain reaction amplification and restriction digestion with HinfI to distinguish the mutant and wild-type alleles.

Preliminary testing
-------------------

Before the trials, each subject's maximal oxygen consumption (VO~2max~) was measured to establish the exercise intensity. Subjects were familiarized with cycling and were informed of what was required of them with regard to the experiment. Next, they completed a cycling exercise test to determine each of their VO~2max~ adhering to the Ramp Protocol. Moreover, one repetition maximum (RM) for each subject according to the American College of Sports Medicine guidelines was measured for resistance training ([@b3-jer-14-2-267]).

Exercise training
-----------------

Exercise training was supervised by four experienced physical education instructors and was performed 5 days a week for six months. Each session consisted of 10 min of warming up, aerobic exercise by 45 min of cycling at 60% VO~2~R for 3 days a week, resistance training at 60%--75% intensity of individual RM in the form of 3 sets with 12--15 repetitions (the chest, back, shoulder, triceps, biceps, abdomen, and lower-extremity muscle group) each for 2 days a week, and 5 min of cooling down.

Statistical analysis
--------------------

All data are presented as means±standard deviation. Changes in risk factors before and after exercise training according to the genotype were analyzed using two-way analysis of variance with repeated measures, and within-group comparisons using a paired *t*-test for *post hoc* analysis. All statistical analyses were performed using IBM SPSS Statistics ver. 20.0 (IBM Co., Armonk, NY, USA), and *P*-values of \<0.05 were considered statistically significant.

RESULTS
=======

The changes in body composition after exercise training according to *APOE* genotype
------------------------------------------------------------------------------------

There were no significant differences in baseline values between the genotypes. After exercise training, body weight (*P*\<0.001), BMI (*P*\<0.001), percent body fat (*P*\<0.05) decreased in the both APOE groups. According to the *APOE* genotype, changes in BMI showed a difference in the interaction between time and group (*P*\<0.05). The change in BMI in the APOE ɛ4 group was significantly higher than that in the APO ɛ3 group (*P*\<0.01) ([Table 2](#t2-jer-14-2-267){ref-type="table"}).

The changes in stroke risk factors after exercise training according to the *APOE* genotype
-------------------------------------------------------------------------------------------

There were no significant differences in baseline values between the two genotypes. After exercise training, TC (*P*\<0.01), LDL-C (*P*\<0.01), TG (*P*\<0.05), and plasma Hcy concentrations (*P*\< 0.05) decreased and HDL-C increased (*P*\<0.05) in both groups significantly. According to the *APOE* genotype, systolic blood pressure (SBP), TC, LDL-C, and TG showed a difference in the interaction between time and group (*P*\<0.05). SBP in the APOE ɛ4 group decreased, but in the APOE ɛ3 group increased after exercise training. TC, LDL-C, and TG in the APOE ɛ4 group decreased more extensively than those in the APOE ɛ3 group after exercise training ([Table 3](#t3-jer-14-2-267){ref-type="table"}).

The changes in cardiorespiratory fitness and cognition after exercise training according to the *APOE* genotype
---------------------------------------------------------------------------------------------------------------

There were no significant differences in baseline values between the two genotypes. After exercise training, the VO~2max~ and cognition increased in both groups (*P*\<0.001). However, there was no difference in these changes according to the *APOE* genotype ([Table 4](#t4-jer-14-2-267){ref-type="table"}).

The changes in vitamin 6 and folate acid intake during exercise training according to the *APOE* genotype
---------------------------------------------------------------------------------------------------------

There were no significant differences in baseline values between the two genotypes. After exercise training, the folate acid intake increased significantly in both groups (*P*\<0.05) ([Table 5](#t5-jer-14-2-267){ref-type="table"}). However, there was no difference in these changes according to the *APOE* genotype.

DISCUSSION
==========

This study showed that lipid levels including TC, LDL-C, and TG decreased and HDL-C increased in both APOE groups after 6 months of exercise training. These results may be explained by the effects of exercise training including, induction favorable changes in blood lipid levels by up-regulation of lipoprotein lipase activity ([@b47-jer-14-2-267]), which regulates the release and transportation of free fatty acids from cyhlomicrons and very low-density lipoproteins to peripheral tissues and liver, consequently leading to a reduction in triglyceride levels ([@b48-jer-14-2-267]).

However, we found different changes in the lipid profiles of two groups including TC, LDL-C, and TG after exercise training. TC, LDL-C, and TG in the APOE ɛ4 group showed a higher reduction than those in the APOE ɛ3 group after exercise training.

APOE is a protein that regulates cholesterol, lipid metabolism, and cellular reparative processes in the circulating plasma and central nervous system ([@b32-jer-14-2-267]). The *APOE* gene has three isoforms, which account for the different affinities of APOE protein for lipoprotein particles and binding to LDL receptors ([@b11-jer-14-2-267]). The APOE ɛ4 allele has been established to have an association with higher circulating cholesterol levels and the buildup of atherosclerotic plaque in peripheral arteries, which leads to an increased risk of cardiovascular disease up to 40% ([@b7-jer-14-2-267]). Individuals with the APOE ɛ4 allele have higher TC and LDL-C levels but lower HDL-C levels compared to those with the APOE ɛ3 allele ([@b14-jer-14-2-267]).

However, the effects of exercise training according to the *APOE* genotype are different. [@b4-jer-14-2-267] suggested that high-intensity physical activity with a high amount of energy expenditure may counteract the atherogenic effects of the APOE ɛ4 allele on lipid profiles. Individuals with the APOE ɛ4 allele who performed high-intensity physical activity with a lot of energy expenditure showed higher HDL-C and lower TG levels compared to individuals with the APOE ɛ3allele ([@b13-jer-14-2-267]). Our results showing that long-term exercise training may induce favorable changes in stroke risk factors including lipid profiles by compensating for the APOE ɛ4 allele in stroke patients are similar to those published in a previous study.

Hyperhomocysteine also has been reported an independent risk factor for ischemic stroke in Asians, including young individuals ([@b45-jer-14-2-267]). Also, mild elevations in Hcy concentrations occurred in 42% of patients with cerebrovascular disease, and [@b27-jer-14-2-267] reported that Hcy is an independent predictor of MMES and a risk factor for the development of dementia ([@b42-jer-14-2-267]).

Despite the results of previous studies on the effects of exercise training on Hcy levels being inconsistent, we found that Hcy concentrations decreased with increasing cardiorespiratory fitness and intake of folate acid in both APOE groups after exercise training.

These results are consistent with those of previous studies, which suggested that Hcy concentrations show a negative correlation with cardiorespiratory fitness in men ([@b23-jer-14-2-267]; [@b33-jer-14-2-267]). However, the effects of increased intake of folate acid on the reduction of Hcy are not clear. Several previous studies have suggested that folate, vitamin B~6~, and B~12~ are important enzymes for Hcy metabolism, and a negative correlation exists between folate intake and Hcy concentration. Despite a lot of studies showing these results, meta-analysis of the correlation between folate intake and Hcy levels showed that the evidence was not sufficient to establish the effects of folic acid supplementation on decreasing the Hcy concentration ([@b26-jer-14-2-267]). The possible favorable effect of folic acid supplementation on Hcy levels is only applicable in early stages of vascular disease, but it is less effective in advanced disease. Our study participants included a chronic stroke patient. Therefore, our results suggest that the lower Hcy concentration after exercise training may be an effect of increase in cardiorespiratory fitness by long-term exercise training.

Prevention and treatment of poststroke dementia involves reducing the risk factors of stroke, and exercise trainings have been conducted for effectively slowing the cognitive decline and improving the risk factors of stroke ([@b19-jer-14-2-267]). However, evidence showing that physical activity or exercise training can prevent or delay cognitive decline remains controversial. Moderate or vigorous physical activity decreases the incidence of cognitive impairment ([@b8-jer-14-2-267]) and exercise training even enhances cognitive function in older individuals ([@b30-jer-14-2-267]). On the other hand, [@b43-jer-14-2-267] could not demonstrate that exercise training prevented or delayed cognitive impairment.

This study showed that cognition increased after 6 months of exercise training but there was no difference between the different *APOE* genotypes. Individuals with the APOE ɛ4 allele have a higher risk of developing dementia and increased cognitive decline ([@b34-jer-14-2-267]; [@b44-jer-14-2-267]), as the APOE ɛ4 allele is associated with multiple pathological impacts, including amyloid deposition and synaptogenesis, the increased accumulation and reduced clearance of amyloid β-peptide, which is a marker for extracellular neuritic plaques in the brain ([@b6-jer-14-2-267]). However, exercise training could improve brain function in individuals with the APOE ɛ4 allele ([@b20-jer-14-2-267]); particularly, those who participated in higher energy expenditure exercise showed greater protection against dementia about 20 years later compared with individuals without the APOE ɛ4 allele. Another study even suggested that the effect of exercise training on reducing risk of cognitive decline was only observed in individuals with the APOE ɛ4 allele ([@b49-jer-14-2-267]).

However, in our study, there was no difference between the two *APOE* genotypes, despite the reduced risk of stroke, including lipid profiles and Hcy concentrations, and the increase in cardiorespiratory fitness. These inconsistencies in the effects of exercise training on cognition according to the *APOE* genotype may be because the neuropathology of vascular cognitive impairment is controversial, and also because cerebrovascular lesions are different in size (from small to large cortical infarcts), nature (vessel wall alteration, infarcts, or hemorrhages, etc.), and location (cortex, white matter, basal ganglia, and hippocampus). Various mechanisms that alter the blood flow and oxygen supply, cortical connectivity, or chronic inflammation in cerebrovascular lesions may have an impact on cognition impairment ([@b18-jer-14-2-267]). [@b10-jer-14-2-267] suggested that poststroke dementia, subcortical ischemic dementia combined with Alzheimer disease and vascular dementia are related to cognitive dysfunction, which extends the pathological changes in cerebrovascular lesions and neuronal atrophy.

This study showed that 6 months of exercise training can result in positive changes in body composition, stroke risk factors including Hcy concentrations, and cognition in stroke patients. The changes in lipid levels showed a difference based on the *APOE* genotype. Lipid levels in the APOE ɛ4 group showed more favorable changes compared to the APOE ɛ3 group after exercise training. However, the changes in Hcy levels and cognition showed no difference according to the *APOE* genotype. Therefore, future studies should more carefully address the precise clinical phenotypes such as size, nature, and location of cerebrovascular lesions in the study participants and enroll a larger population for the analysis of *APOE* genotype.
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###### 

Characteristics of participants

  Variable                       Genotype      *t*          Sig.     
  ------------------------------ ------------- ------------ -------- -------
  Age (yr)                       56.80±10.65   56.67±9.19   0.037    0.971
  Region of attack, right:left   4:9           4:11         −0.728   0.473
  Period of stroke (yr)          2.27±1.79     2.07±1.39    0.342    0.735

Values are presented as mean±standard deviation.

###### 

Changes in body composition after exercise training according to the *APOE* genotype

  Variable                            Genotype      *F*           Sig.                                                         
  ---------------------- ------------ ------------- ------------- ------- ---------------------------------------------------- --------------------------------------------------------
  Body weight (kg)       Pre          64.79±7.15    63.66±10.52   Time    56.134                                               0.000[\*\*\*](#tfn5-jer-14-2-267){ref-type="table-fn"}
                                                    Group         0.228   0.637                                                
  Post                   63.20±7.37   61.17±10.66   T×G           2.723   0.110                                                
                                                                                                                               
  BMI (kg/m^2^)          Pre          24.57±2.71    24.42±3.52    Time    16.535                                               0.000[\*\*\*](#tfn5-jer-14-2-267){ref-type="table-fn"}
                                                    Group         0.585   0.451                                                
  Post                   24.11±2.88   22.63±2.89    T×G           5.848   0.022[\*](#tfn4-jer-14-2-267){ref-type="table-fn"}   
                                                                                                                               
  Muscle mass (kg)       Pre          42.04±7.28    44.37±9.158   Time    0.866                                                0.360
                                                    Group         0.425   0.520                                                
  Post                   41.98±8.28   43.54±8.30    T×G           0.627   0.435                                                
                                                                                                                               
  Percent body fat (%)   Pre          29.18±7.416   24.44±6.45    Time    7.330                                                0.011[\*](#tfn4-jer-14-2-267){ref-type="table-fn"}
                                                    Group         3.680   0.065                                                
  Post                   28.00±9.49   22.46±6.22    T×G           0.474   0.497                                                

Values are presented as mean±standard deviation.

BMI, body mass index.

*P*\<0.05.

*P*\<0.001.

###### 

Changes in stroke risk factors after exercise training according to the *APOE* genotype

  Variable                                      Genotype       *F*            Sig.                                                         
  ------------------------------ -------------- -------------- -------------- ------- ---------------------------------------------------- ------------------------------------------------------
  SBP (mmHg)                     Pre            124.20±7.58    118.46±11.35   Time    0.344                                                0.562
                                                               Group          0.223   0.641                                                
  Post                           119.13±9.87    121.33±15.55   T×G            4.473   0.043[\*](#tfn8-jer-14-2-267){ref-type="table-fn"}   
                                                                                                                                           
  DBP (mmHg)                     Pre            82.400±8.42    79.60±12.47    Time    0.056                                                0.814
                                                               Group          0.001   0.972                                                
  Post                           80.13±8.11     82.73±7.44     T×G            2.185   0.151                                                
                                                                                                                                           
  Fasting glucose (mg/L)         Pre            112.13±30.11   110.00±23.81   Time    2.295                                                0.141
                                                               Group          0.003   0.959                                                
  Post                           105.20±21.53   108.26±26.20   T×G            0.826   0.371                                                
                                                                                                                                           
  TC (mg/dL)                     Pre            199.06±40.69   192.93±34.91   Time    8.434                                                0.007[\*\*](#tfn9-jer-14-2-267){ref-type="table-fn"}
                                                               Group          0.155   0.697                                                
  Post                           174.20±32.08   189.73±32.85   T×G            5.026   0.033[\*](#tfn8-jer-14-2-267){ref-type="table-fn"}   
                                                                                                                                           
  LDL-C (mg/L)                   Pre            325.86±40.31   302.20±54.47   Time    9.471                                                0.005[\*\*](#tfn9-jer-14-2-267){ref-type="table-fn"}
                                                               Group          0.447   0.509                                                
  Post                           294.26±36.36   297.20±48.53   T×G            5.003   0.033[\*](#tfn8-jer-14-2-267){ref-type="table-fn"}   
                                                                                                                                           
  HDL-C (mg/L)                   Pre            53.40±14.64    55.86±9.76     Time    5.552                                                0.026[\*](#tfn8-jer-14-2-267){ref-type="table-fn"}
                                                               Group          0.123   0.728                                                
  Post                           57.06±15.52    57.80±10.68    T×G            0.532   0.472                                                
                                                                                                                                           
  Triglycerides (mg/L)           Pre            146.60±72.45   139.73±94.12   Time    6.683                                                0.015[\*](#tfn8-jer-14-2-267){ref-type="table-fn"}
                                                               Group          0.176   0.678                                                
  Post                           109.86±59.10   139.93±82.34   T×G            6.831   0.014[\*](#tfn8-jer-14-2-267){ref-type="table-fn"}   
                                                                                                                                           
  Homocysteine levels (μmol/L)   Pre            17.01±6.91     13.49±4.41     Time    5.936                                                0.021[\*](#tfn8-jer-14-2-267){ref-type="table-fn"}
                                                               Group          3.203   0.084                                                
  Post                           15.93±5.55     12.52±4.46     T×G            0.016   0.899                                                

Values are presented as mean±standard deviation.

SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.

*P*\<0.05.

*P*\<0.01.

###### 

Changes in physical fitness and cognition after exercise training according to the *APOE* genotype

  Variable                             Genotype      *F*           Sig.             
  ---------------------- ------------- ------------- ------------- ------- -------- ---------------------------------------------------------
  VO~2max~ (mL/kg/min)   Pre           22.59±11.61   29.73±10.17   Time    37.852   0.000[\*\*\*](#tfn11-jer-14-2-267){ref-type="table-fn"}
                                                     Group         1.664   0.208    
  Post                   32.50±11.88   35.47±11.37   T×G           2.682   0.113    
                                                                                    
  Cognition (score)      Pre           25.13±2.92    25.00±4.45    Time    22.609   0.000[\*\*\*](#tfn11-jer-14-2-267){ref-type="table-fn"}
                                                     Group         0.003   0.955    
  Post                   27.33±2.71    27.60±3.52    T×G           0.157   0.695    

Values are presented as mean±standard deviation.

*P*\<0.001.

###### 

Changes in body composition after exercise training according to the *APOE* genotype

  Variable                            Genotype       *F*            Sig.            
  ------------------- --------------- -------------- -------------- ------- ------- -------
  Vitamin ~6~ (mg)    Pre             1.90±0.55      1.60±0.43      Time    0.686   0.418
                                                     Group          0.393   0.538   
  Post                1.86±0.64       1.93±0.66      T×G            1.082   0.311   
                                                                                    
  Vitamin ~12~ (mg)   Pre             188.42±55.53   215.86±62.82   Time    6.600   0.019
                                                     Group          0.000   0.984   
  Post                275.79±113.77   249.49±84.14   T×G            1.302   0.268   

Values are presented as mean±standard deviation.
